Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study.

Bagatell R, Gore L, Egorin MJ, Ho R, Heller G, Boucher N, Zuhowski EG, Whitlock JA, Hunger SP, Narendran A, Katzenstein HM, Arceci RJ, Boklan J, Herzog CE, Whitesell L, Ivy SP, Trippett TM.

Clin Cancer Res. 2007 Mar 15;13(6):1783-8.

2.

A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancy.

Seddon BM, Payne GS, Simmons L, Ruddle R, Grimshaw R, Tan S, Turner A, Raynaud F, Halbert G, Leach MO, Judson I, Workman P.

Clin Cancer Res. 2003 Nov 1;9(14):5101-12. Review.

3.

Pediatric phase I trials in oncology: an analysis of study conduct efficiency.

Lee DP, Skolnik JM, Adamson PC.

J Clin Oncol. 2005 Nov 20;23(33):8431-41. Review.

PMID:
16293874
4.

Clinical pharmacokinetics and pharmacodynamics of anticancer agents in pediatric patients (review).

Knoester PD, Underberg WJ, Beijnen JH.

Anticancer Res. 1993 Sep-Oct;13(5C):1795-808. Review.

PMID:
8267385
5.

Metronomic dosing of chemotherapy: applications in pediatric oncology.

Stempak D, Seely D, Baruchel S.

Cancer Invest. 2006 Jun-Jul;24(4):432-43. Review.

PMID:
16777697

Supplemental Content

Write to the Help Desk